MedPage Today  Jun 20  Comment 
(MedPage Today) -- Fecal immunochemical testing good for CRC, but not advanced neoplasia
GenEng News  Jun 12  Comment 
XBiotech has discontinued the Phase III XCITE study evaluating its lead True Human™ anti-interleukin-1α monoclonal antibody (mAb) Xilonix ™ in the treatment of patients with advanced colorectal cancer (CRC) on efficacy grounds. The study’s...
Benzinga  May 31  Comment 
Baird reiterated its Outperform rating on Exact Sciences Corporation (NASDAQ: EXAS) as analyst Catherine Schulte set a new $40 price target. 3 Key Points Strong Management Team: Schulte highlighted Exact Sciences' strong management, with its...
GenEng News  May 19  Comment 
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion on XBiotech’s lead product, its human interleukin-1α monoclonal antibody (mAb), and recommended against approval of the mAb...
The Economic Times  May 13  Comment 
The El Nino bulletin issued by the US Climate Prediction Center (CRC) and other agencies shows a slightly higher probability for neutral conditions to continue during August and September.
GenEng News  May 8  Comment 
Array BioPharma and Merck agreed to carry out a clinical trial combining Array’s oral MEK inhibitor binimetinib with Merck’s anti-programmed cell death protein 1 (anti-PD-1) therapy Keytruda ® (pembrolizumab) in patients with metastatic...
Motley Fool  May 5  Comment 
Higher oil prices, free cash flow generation, and some new joint venture deals have Wall Street excited for this oil producer.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki